Thrombolytics play an important part in the treatment of ST-segment elevation myocardial infarction

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.26, Iss.9, 2010-09, pp. : 10-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing the Use of Thrombolytics in ST-Segment Elevation Myocardial Infarction

By Morse Michael A. Todd Josh W. Stouffer George A.

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 1945-1966

Adis International

Access to resources Recommend Favorite

Antithrombotic therapy in ST-segment elevation myocardial infarction

By Wong Cheuk-Kit White Harvey D

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 213-223

Informa Healthcare

Access to resources Recommend Favorite

Bivalirudin: In Patients with ST-Segment Elevation Myocardial Infarction

By Curran Monique P.

Drugs, Vol. 70, Iss. 7, 2010-05 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite

Clopidogrel Bisulfate: In ST-Segment Elevation Myocardial Infarction

By Dickie Jennifer S. Scott Lesley J.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 407-414

Adis International

Access to resources Recommend Favorite

Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction

By Lexis Chris Wieringa Wouter Hiemstra Bart Deursen Vincent Lipsic Erik Harst Pim Veldhuisen Dirk Horst Iwan

Cardiovascular Drugs and Therapy, Vol. 28, Iss. 2, 2014-04 ,pp. : 163-171

Springer Publishing Company

Access to resources Recommend Favorite